Fusion Pharmaceuticals Inc
(FUSN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2006 | 12-1999 | 12-1998 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,652 | N/A | N/A | -7,160 | -26,440 |
| Depreciation Amortization | 114 | N/A | N/A | 0 | 0 |
| Income taxes - deferred | -19 | N/A | N/A | 0 | 0 |
| Accounts payable and accrued liabilities | -381 | N/A | N/A | 0 | 0 |
| Other Working Capital | -572 | N/A | N/A | 0 | 0 |
| Other Operating Activity | 2,644 | 0 | 0 | 5,240 | 18,700 |
| Operating Cash Flow | $-9,866 | $N/A | $N/A | $-1,920 | $-7,740 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,123 | N/A | N/A | 0 | 0 |
| Other Investing Activity | 0 | 0 | 0 | 1,900 | 410 |
| Investing Cash Flow | $-1,123 | $N/A | $N/A | $1,900 | $410 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 18,369 | 0 | 0 | 150 | 7,100 |
| Financing Cash Flow | $18,369 | $N/A | $N/A | $150 | $7,100 |
| Beginning Cash Position | 21,700 | N/A | N/A | 380 | 600 |
| End Cash Position | 29,080 | N/A | N/A | 510 | 380 |
| Net Cash Flow | $7,380 | $N/A | $N/A | $120 | $-210 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,866 | N/A | N/A | -1,920 | -7,740 |
| Capital Expenditure | -1,123 | N/A | N/A | 0 | 0 |
| Free Cash Flow | -10,989 | 0 | 0 | -1,920 | -7,740 |